The danger period for patients with M3 leukemia is usually about one month.
Acute myeloid leukemia M3 is an acute promyelocytic leukemia, mainly caused by thrombocytopenia and coagulation disorders, with symptoms such as intracranial hemorrhage, respiratory difficulties, and even coma or death.
Generally speaking, most M3 leukemia patients can be cured by chemotherapy, but the first month of M3 leukemia treatment is a very dangerous period with the risk of bleeding and infection. Therefore, the first month should pay more attention to care and closely observe the actual condition of the patient, while the later treatment is based on consolidation and maintenance therapy.
After the occurrence of M3 leukemia, you need to actively cooperate with doctors for treatment, do not delay the condition, so as not to increase the difficulty of treatment and pose a threat to the life and health of patients.